Agência para o Investimento e Comércio Externo de Portugal


Greece’s pharmaceutical sector.

Greece’s pharmaceutical sector has been growing at a fast pace during the past five years (with sales up by 80%, vs 43% in the EU and 7% for other Greek manufacturing) – with exports being the main growth engine (with its extroversion increasing to 50% of sales in 2021 vs 30% in 2016). Noteworthy is the fact that the sector’s investment appetite is gradually recovering, with the gross fixed capital formation-to-sales ratio reaching c. 10% (up from 7% five years ago and c. 15% in the EU).


More here and here.